Patent details

EP3321276 Title: FUSION PROTEINS FOR TREATING METABOLIC DISORDERS

Basic Information

Publication number:
EP3321276
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP172019572
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FUSION PROTEINS FOR TREATING METABOLIC DISORDERS
French Title of Invention:
PROTÉINES DE FUSION POUR TRAITEMENT DE SYNDROMES MÉTABOLIQUES
German Title of Invention:
FUSIONSPROTEINE ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN
SPC Number:

Dates

Filing date:
26/09/2012
Grant date:
28/07/2021
EP Publication Date:
16/05/2018
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/07/2021
EP B1 Publication Date:
28/07/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
26/09/2032
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
21/07/2021
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Agent

Name:
WEICKMANN & WEICKMANN
From:
03/09/2021
Address:
Postfach 860 820, 81635 München, Germany (DE)
To:

Inventor

1

Name:
CAPLAN, Shari L.
Address:
United States (US)

2

Name:
BOETTCHER, Brian R.
Address:
United States (US)

3

Name:
DANIELS, Douglas S.
Address:
United States (US)

4

Name:
HAMAMATSU, Norio
Address:
United States (US)

5

Name:
LICHT, Stuart
Address:
United States (US)

6

Name:
WELDON, Stephen Craig
Address:
United States (US)

Priority

Priority Number:
201161539280 P
Priority Date:
26/09/2011
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/00; A61K 38/18; A61P 1/00; A61P 1/16; A61P 1/18; A61P 3/00; C07K 14/50; A61P 3/04; A61P 3/06; A61P 3/08; A61P 3/10; A61P 43/00;

Publication

European Patent Bulletin

Issue number:
202130
Publication date:
28/07/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/09/2025
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
18/09/2024
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
DENNEMEYER & CO
Filing date Document type Number of pages
03/09/2021 Power Of Attorney 4
03/09/2021 Outgoing Correspondence 1